Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Repare Therapeutics Inc. Director's Dealing 2021

Sep 9, 2021

34365_dirs_2021-09-09_d6fb0341-3ae0-4962-90c2-0019019986ec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Repare Therapeutics Inc. (RPTX)
CIK: 0001808158
Period of Report: 2021-09-07

Reporting Person: Civik Thomas (Director)